John Lucas
Physician Assistant · Wilson, NCNPI 1306998216
Payments from drug & device makers
Across 195 payments — averaging $15.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$639
- AbbVie$526
- AstraZeneca$293
- Amgen$224
- Pfizer$202
- GSK$189
- plus $870 from 19 others
What the payments were for
- Food & beverage$2,944100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 41 | $639 |
| AbbVie | 37 | $526 |
| AstraZeneca | 21 | $293 |
| Amgen | 14 | $224 |
| Pfizer | 13 | $202 |
| GSK | 15 | $189 |
| Boehringer Ingelheim | 8 | $125 |
| Merck | 6 | $91 |
| Esperion Therapeutics, Inc. | 5 | $89 |
| Abbott | 5 | $87 |
| Lilly USA, LLC | 6 | $86 |
| Sanofi-aventis U.S. LLC | 6 | $81 |
| Amarin Pharma, Inc. | 3 | $52 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 2 | $36 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $34 |
| Eisai Inc. | 2 | $30 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Amneal Pharmaceuticals LLC | 1 | $22 |
| Sanofi Pasteur Inc. | 1 | $20 |
| Bayer | 1 | $18 |
| Exact Sciences | 1 | $18 |
| Idorsia Pharmaceuticals US Inc | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Novartis | 1 | $12 |
| Cequr Corporation | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,944 in reported general payments places this provider in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 15 | $14,798 |
| JanuviaSitagliptin Phosphate | 11 | $5,855 |
| Atorvastatin Calcium | 95 | $973 |
| Amlodipine Besylate | 85 | $641 |
| Omeprazole | 29 | $551 |
| Rosuvastatin Calcium | 49 | $506 |
| Losartan Potassium | 34 | $477 |
| Tamsulosin Hcl | 25 | $473 |
| Valsartan | 11 | $444 |
| Potassium Chloride | 14 | $428 |
| Levothyroxine Sodium | 30 | $378 |
| Gabapentin | 25 | $347 |
| Esomeprazole Magnesium | 11 | $344 |
| ValacyclovirValacyclovir Hcl | 11 | $337 |
| Lisinopril | 36 | $326 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $202 | $14,79815 claims |
| MerckJanuvia | $91 | $5,85511 claims |
| Amneal Pharmaceuticals LLCLevothyroxine Sodium | $22 | $37830 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Wilson
- Philip ReasbeckWilson$180K
- Frank FerrittoWilson$90K
- James KovachWilson$59K
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Katherine SchultzHuntersville$164K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.